-
公开(公告)号:US20140113909A1
公开(公告)日:2014-04-24
申请号:US14124734
申请日:2012-06-28
申请人: Sunkyu Kim , Shivang Doshi , Kristy Hans , Steven Kovats
发明人: Sunkyu Kim , Shivang Doshi , Kristy Hans , Steven Kovats
IPC分类号: A61K31/519 , A61K31/506
CPC分类号: A61K31/519 , A61K31/506 , A61K45/06 , A61K2300/00
摘要: A combination of a CDK4/6 inhibitor and an FGFR kinase inhibitor for the treatment of cancer.
摘要翻译: 用于治疗癌症的CDK4 / 6抑制剂和FGFR激酶抑制剂的组合。
-
公开(公告)号:US10010552B2
公开(公告)日:2018-07-03
申请号:US15003860
申请日:2016-01-22
申请人: Sunkyu Kim , Shivang Doshi , Kristy Haas , Steven Kovats , Alan Xizhong Huang , Yan Chen
发明人: Sunkyu Kim , Shivang Doshi , Kristy Haas , Steven Kovats , Alan Xizhong Huang , Yan Chen
IPC分类号: A61K31/519 , C07D487/02 , A61K31/4439 , A61K45/06 , A61K31/5377
CPC分类号: A61K31/519 , A61K31/4439 , A61K31/5377 , A61K45/06 , A61K2300/00
摘要: A combination of a CDK4/6 inhibitor and a P3Kinase inhibitor for the treatment of cancer.
-
3.Combination Therapy Comprising A CDK4/6 Inhibitor and a PI3K Inhibitor for Use in the Treatment of Cancer 审中-公开
标题翻译: 包含用于治疗癌症的CDK4 / 6抑制剂和PI3K抑制剂的组合疗法公开(公告)号:US20160136171A1
公开(公告)日:2016-05-19
申请号:US15003860
申请日:2016-01-22
申请人: Sunkyu Kim , Shivang Doshi , Kristy Haas , Steven Kovats , Alan Xizhong Huang , Yan Chen
发明人: Sunkyu Kim , Shivang Doshi , Kristy Haas , Steven Kovats , Alan Xizhong Huang , Yan Chen
IPC分类号: A61K31/519 , A61K31/4439 , A61K31/5377
CPC分类号: A61K31/519 , A61K31/4439 , A61K31/5377 , A61K45/06 , A61K2300/00
摘要: A combination of a CDK4/6 inhibitor and a P3Kinase inhibitor for the treatment of cancer.
摘要翻译: CDK4 / 6抑制剂与用于治疗癌症的P3Kinase抑制剂的组合。
-
4.Combination therapy comprising a CDK4/6 inhibitor and a P13K inhibitor for use in the treatment of cancer 有权
标题翻译: 包含用于治疗癌症的CDK4 / 6抑制剂和P13K抑制剂的组合疗法公开(公告)号:US09271988B2
公开(公告)日:2016-03-01
申请号:US14124753
申请日:2012-07-02
申请人: Sunkyu Kim , Shivang Doshi , Kristy Haas , Steven Kovats , Alan Xizhong Huang , Yan Chen
发明人: Sunkyu Kim , Shivang Doshi , Kristy Haas , Steven Kovats , Alan Xizhong Huang , Yan Chen
IPC分类号: A61K31/519 , A61K31/5377 , C07D487/02 , A61K31/4439 , A61K45/06
CPC分类号: A61K31/519 , A61K31/4439 , A61K31/5377 , A61K45/06 , A61K2300/00
摘要: A combination of a CDK4/6 inhibitor and a P3Kinase inhibitor for the treatment of cancer.
摘要翻译: CDK4 / 6抑制剂与用于治疗癌症的P3Kinase抑制剂的组合。
-
5.Combination Therapy Comprising A CDK4/6 Inhibitor and a P13K Inhibitor for Use in the Treatment of Cancer 有权
标题翻译: 包含用于治疗癌症的CDK4 / 6抑制剂和P13K抑制剂的组合疗法公开(公告)号:US20140107114A1
公开(公告)日:2014-04-17
申请号:US14124753
申请日:2012-07-02
申请人: Sunkyu Kim , Shivang Doshi , Kristy Haas , Steven Kovats , Alan Xizhong Huang , Yan Chen
发明人: Sunkyu Kim , Shivang Doshi , Kristy Haas , Steven Kovats , Alan Xizhong Huang , Yan Chen
IPC分类号: A61K31/5377 , A61K31/4439 , A61K31/519
CPC分类号: A61K31/519 , A61K31/4439 , A61K31/5377 , A61K45/06 , A61K2300/00
摘要: A combination of a CDK4/6 inhibitor and a P3Kinase inhibitor for the treatment of cancer.
摘要翻译: CDK4 / 6抑制剂与用于治疗癌症的P3Kinase抑制剂的组合。
-
公开(公告)号:US09408847B2
公开(公告)日:2016-08-09
申请号:US14646206
申请日:2013-11-25
申请人: Shivang Doshi , Sunkyu Kim
发明人: Shivang Doshi , Sunkyu Kim
IPC分类号: A61K31/519 , A61K31/436 , A61K45/06
CPC分类号: A61K31/519 , A61K31/436 , A61K45/06 , A61K2300/00
摘要: The present invention relates to a pharmaceutical combination comprising (1) a first agent which is a CDK inhibitor or a pharmaceutically acceptable salt thereof and (2) a second agent which is a mTOR inhibitor or a pharmaceutically acceptable salt thereof.
摘要翻译: 本发明涉及药物组合,其包含(1)作为CDK抑制剂或其药学上可接受的盐的第一药剂和(2)作为mTOR抑制剂或其药学上可接受的盐的第二药剂。
-
公开(公告)号:US20150306104A1
公开(公告)日:2015-10-29
申请号:US14646206
申请日:2013-11-25
申请人: Shivang Doshi , Sunkyu Kim
发明人: Shivang Doshi , Sunkyu Kim
IPC分类号: A61K31/519 , A61K31/436
CPC分类号: A61K31/519 , A61K31/436 , A61K45/06 , A61K2300/00
摘要: The present invention relates to a pharmaceutical combination comprising (1) a first agent which is a CDK inhibitor or a pharmaceutically acceptable salt thereof and (2) a second agent which is a mTOR inhibitor or a pharmaceutically acceptable salt thereof.
摘要翻译: 本发明涉及药物组合,其包含(1)作为CDK抑制剂或其药学上可接受的盐的第一药剂和(2)作为mTOR抑制剂或其药学上可接受的盐的第二药剂。
-
8.Combination Comprising a Cyclin Dependent Kinase 4 or Cyclin Dependent Kinase (CDK4/6) Inhibitor for Treating Cancer 审中-公开
标题翻译: 包含细胞周期蛋白依赖性激酶4或细胞周期蛋白依赖性激酶(CDK4 / 6)抑制剂治疗癌症的组合公开(公告)号:US20160008367A1
公开(公告)日:2016-01-14
申请号:US14800893
申请日:2015-07-16
申请人: Maria Borland , Christopher Thomas Brain , Shivang Doshi , Sunkyu Kim , Jianguo Ma , Josh Murtie , Hong Zhang
发明人: Maria Borland , Christopher Thomas Brain , Shivang Doshi , Sunkyu Kim , Jianguo Ma , Josh Murtie , Hong Zhang
IPC分类号: A61K31/519 , A61K31/436
CPC分类号: A61K31/519 , A61K31/436 , A61K45/06 , A61K2300/00
摘要: A combination of a CDK4/6 inhibitor and an mTOR inhibitor for the treatment of cancer.
摘要翻译: CDK4 / 6抑制剂和用于治疗癌症的mTOR抑制剂的组合。
-
9.COMBINATION COMPRISING A CYCLIN DEPENDENT KINASE 4 OR CYCLIN DEPENDENT KINASE (CDK4/6) INHIBITOR FOR TREATING CANCER 审中-公开
标题翻译: 包含依赖循环激酶4或循环激酶(CDK4 / 6)抑制剂治疗癌症的组合公开(公告)号:US20130035336A1
公开(公告)日:2013-02-07
申请号:US13640863
申请日:2011-04-12
申请人: Maria Borland , Christopher Thomas Brain , Shivang Doshi , Sunkyu Kim , Jianguo Ma , Josh Murtie , Hong Zhang
发明人: Maria Borland , Christopher Thomas Brain , Shivang Doshi , Sunkyu Kim , Jianguo Ma , Josh Murtie , Hong Zhang
IPC分类号: A61K31/5377 , A61P35/02 , A61P35/00 , A61K31/5025 , A61K31/439
CPC分类号: A61K31/519 , A61K31/436 , A61K45/06 , A61K2300/00
摘要: A combination of a CDK4/8 inhibitor and an mTOR inhibitor for the treatment of cancer.
摘要翻译: CDK4 / 8抑制剂和用于治疗癌症的mTOR抑制剂的组合。
-
公开(公告)号:US20150322528A1
公开(公告)日:2015-11-12
申请号:US14408893
申请日:2013-06-26
申请人: Giordano Caponigro , Scott Delach , Levi Garraway , Zainab Jagani , Sunkyu Kim , Gregory Kryukov
发明人: Giordano Caponigro , Scott Delach , Levi Garraway , Zainab Jagani , Sunkyu Kim , Gregory Kryukov
IPC分类号: C12Q1/68 , A61K31/506 , A61K31/519 , A61K31/454 , G01N33/574 , G01N33/50
CPC分类号: C12Q1/6886 , A61K31/454 , A61K31/506 , A61K31/519 , C12Q2600/106 , C12Q2600/156 , C12Q2600/158 , C12Q2600/16 , G01N33/5011 , G01N33/57496 , G01N2333/4739 , G01N2440/14 , G01N2500/04 , G01N2500/10
摘要: The invention provides methods of monitoring differential gene expression of biomarkers to determine patient sensitivity to Cyclin Dependent kinase inhibitors (CDKi), methods of determining the sensitivity of a cell to a CDKi, methods of treating a patient with a CDKi and methods of screening for candidate CDKi.
摘要翻译: 本发明提供了监测生物标志物的差异基因表达以确定患者对细胞周期蛋白依赖性激酶抑制剂(CDKi)的敏感性的方法,确定细胞对CDKi的敏感性的方法,用CDKi治疗患者的方法和筛选候选者的方法 CDKi。
-
-
-
-
-
-
-
-
-